Your browser doesn't support javascript.
loading
Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD.
Janson, Christer; Stratelis, Georgios; Miller-Larsson, Anna; Harrison, Tim W; Larsson, Kjell.
Afiliação
  • Janson C; Respiratory, Allergy and Sleep Research Unit, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Stratelis G; Respiratory, Allergy and Sleep Research Unit, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Miller-Larsson A; Respiratory, Inflammation and Autoimmunity, AstraZeneca Nordic, Södertälje, Sweden.
  • Harrison TW; Respiratory GMed, AstraZeneca Gothenburg, Mölndal, Sweden.
  • Larsson K; Nottingham Respiratory Research Unit, City Hospital Campus, University of Nottingham, Nottingham, UK.
Int J Chron Obstruct Pulmon Dis ; 12: 3055-3064, 2017.
Article em En | MEDLINE | ID: mdl-29089754
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia / Corticosteroides / Budesonida / Doença Pulmonar Obstrutiva Crônica / Fluticasona / Pulmão Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia / Corticosteroides / Budesonida / Doença Pulmonar Obstrutiva Crônica / Fluticasona / Pulmão Idioma: En Ano de publicação: 2017 Tipo de documento: Article